Rare
lephants
Screener
Toggle theme
Eli Lilly and Company
LLY
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2023
$5.80
$5.26
FY2024
$11.71
$6.13
FY2025
$22.95
$8.13
Download CSV
